Mary Weiser-Evans
Concepts (421)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocytes, Smooth Muscle | 21 | 2023 | 235 | 4.220 |
Why?
| PTEN Phosphohydrolase | 13 | 2020 | 140 | 3.980 |
Why?
| Muscle, Smooth, Vascular | 25 | 2023 | 407 | 3.840 |
Why?
| Vascular Remodeling | 8 | 2022 | 152 | 2.820 |
Why?
| Atherosclerosis | 4 | 2023 | 342 | 2.360 |
Why?
| Plaque, Atherosclerotic | 2 | 2023 | 46 | 1.680 |
Why?
| Adventitia | 2 | 2022 | 37 | 1.330 |
Why?
| Kruppel-Like Transcription Factors | 2 | 2020 | 61 | 1.220 |
Why?
| Stem Cells | 6 | 2023 | 538 | 1.140 |
Why?
| Fibrosis | 12 | 2023 | 452 | 1.130 |
Why?
| Lung Neoplasms | 19 | 2023 | 2148 | 1.090 |
Why?
| Mice | 42 | 2023 | 14679 | 1.000 |
Why?
| Vascular System Injuries | 3 | 2023 | 66 | 0.990 |
Why?
| Cell Proliferation | 18 | 2021 | 2164 | 0.950 |
Why?
| Myofibroblasts | 2 | 2023 | 115 | 0.930 |
Why?
| Neointima | 4 | 2022 | 13 | 0.850 |
Why?
| Animals | 62 | 2023 | 31162 | 0.850 |
Why?
| Hypercholesterolemia | 1 | 2023 | 90 | 0.820 |
Why?
| Tunica Intima | 5 | 2010 | 78 | 0.800 |
Why?
| Spinocerebellar Ataxias | 1 | 2022 | 4 | 0.800 |
Why?
| Galectin 3 | 1 | 2022 | 18 | 0.800 |
Why?
| Cell Differentiation | 10 | 2023 | 1681 | 0.780 |
Why?
| Heart-Assist Devices | 4 | 2022 | 493 | 0.750 |
Why?
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 13 | 0.700 |
Why?
| Mice, Inbred C57BL | 21 | 2023 | 4617 | 0.670 |
Why?
| Serum Response Factor | 3 | 2016 | 28 | 0.670 |
Why?
| Carotid Artery Injuries | 5 | 2010 | 42 | 0.660 |
Why?
| Chemokine CXCL12 | 2 | 2011 | 74 | 0.650 |
Why?
| Coronary Restenosis | 1 | 2019 | 18 | 0.650 |
Why?
| Cyclin D1 | 1 | 2019 | 61 | 0.650 |
Why?
| Coronary Vessels | 2 | 2018 | 231 | 0.640 |
Why?
| High-Throughput Screening Assays | 1 | 2020 | 123 | 0.630 |
Why?
| Tumor Microenvironment | 8 | 2021 | 428 | 0.590 |
Why?
| Arteries | 4 | 2022 | 244 | 0.570 |
Why?
| Rats | 20 | 2019 | 4829 | 0.560 |
Why?
| Vascular Diseases | 1 | 2019 | 231 | 0.550 |
Why?
| Mice, Knockout | 15 | 2021 | 2523 | 0.550 |
Why?
| Mice, Transgenic | 9 | 2020 | 1925 | 0.520 |
Why?
| Heparan Sulfate Proteoglycans | 4 | 2003 | 21 | 0.520 |
Why?
| Cells, Cultured | 17 | 2021 | 3802 | 0.510 |
Why?
| Carcinoma, Non-Small-Cell Lung | 7 | 2023 | 953 | 0.500 |
Why?
| PPAR gamma | 7 | 2019 | 179 | 0.490 |
Why?
| Gene Expression Regulation | 5 | 2019 | 2293 | 0.480 |
Why?
| Hypertension | 1 | 2022 | 1051 | 0.470 |
Why?
| Hypertension, Pulmonary | 5 | 2023 | 1733 | 0.470 |
Why?
| Acute Kidney Injury | 5 | 2023 | 676 | 0.460 |
Why?
| Disease Models, Animal | 16 | 2023 | 3470 | 0.460 |
Why?
| Signal Transduction | 18 | 2019 | 4439 | 0.460 |
Why?
| Cell Division | 8 | 2004 | 745 | 0.450 |
Why?
| MicroRNAs | 2 | 2017 | 598 | 0.430 |
Why?
| Hyperplasia | 5 | 2020 | 163 | 0.420 |
Why?
| Protein Kinases | 4 | 2014 | 300 | 0.400 |
Why?
| Bone Marrow Cells | 2 | 2011 | 262 | 0.380 |
Why?
| Transforming Growth Factor beta1 | 3 | 2023 | 152 | 0.370 |
Why?
| Kidney | 6 | 2021 | 1179 | 0.370 |
Why?
| Cell Movement | 5 | 2012 | 852 | 0.360 |
Why?
| Ureteral Obstruction | 3 | 2021 | 54 | 0.360 |
Why?
| Macrophages | 4 | 2021 | 1233 | 0.360 |
Why?
| Muscle, Smooth | 2 | 2023 | 143 | 0.340 |
Why?
| Autocrine Communication | 2 | 2014 | 42 | 0.320 |
Why?
| Angiotensin II | 3 | 2021 | 85 | 0.320 |
Why?
| Cell Dedifferentiation | 3 | 2016 | 28 | 0.320 |
Why?
| Phospholipases A2, Cytosolic | 1 | 2009 | 5 | 0.320 |
Why?
| Cisplatin | 3 | 2020 | 261 | 0.310 |
Why?
| Male | 25 | 2023 | 55112 | 0.310 |
Why?
| Platelet-Derived Growth Factor | 4 | 2020 | 80 | 0.310 |
Why?
| Group IV Phospholipases A2 | 3 | 2017 | 43 | 0.300 |
Why?
| Hypoxia | 2 | 2013 | 919 | 0.290 |
Why?
| Heart Failure | 4 | 2023 | 1955 | 0.290 |
Why?
| Carcinoma, Lewis Lung | 2 | 2019 | 13 | 0.290 |
Why?
| Proteins | 2 | 2006 | 890 | 0.290 |
Why?
| Rats, Sprague-Dawley | 9 | 2016 | 2139 | 0.290 |
Why?
| Proto-Oncogene Proteins c-akt | 7 | 2014 | 394 | 0.280 |
Why?
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2004 | 34 | 0.280 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 4 | 2019 | 27 | 0.280 |
Why?
| Nuclear Proteins | 2 | 2023 | 584 | 0.280 |
Why?
| Actins | 3 | 2018 | 373 | 0.270 |
Why?
| TOR Serine-Threonine Kinases | 5 | 2014 | 357 | 0.270 |
Why?
| Proto-Oncogene Proteins | 3 | 2004 | 595 | 0.260 |
Why?
| Adenocarcinoma | 5 | 2017 | 787 | 0.260 |
Why?
| Inflammation | 4 | 2023 | 2444 | 0.260 |
Why?
| Endothelial Cells | 2 | 2022 | 677 | 0.260 |
Why?
| Acetyltransferases | 1 | 2006 | 19 | 0.260 |
Why?
| Polycystic Kidney, Autosomal Dominant | 2 | 2019 | 209 | 0.260 |
Why?
| Protein-Tyrosine Kinases | 3 | 2003 | 390 | 0.250 |
Why?
| RNA Interference | 5 | 2014 | 426 | 0.240 |
Why?
| Embryonic Development | 1 | 2006 | 112 | 0.240 |
Why?
| Humans | 32 | 2023 | 113531 | 0.240 |
Why?
| Phosphatidylinositol 3-Kinases | 4 | 2010 | 324 | 0.240 |
Why?
| Myeloid Cells | 2 | 2019 | 125 | 0.240 |
Why?
| Gene Expression | 3 | 2014 | 1397 | 0.230 |
Why?
| Ribosomal Protein S6 | 1 | 2004 | 15 | 0.230 |
Why?
| Inflammation Mediators | 2 | 2021 | 469 | 0.220 |
Why?
| Corn Oil | 1 | 2023 | 3 | 0.220 |
Why?
| Receptors, LDL | 1 | 2023 | 38 | 0.220 |
Why?
| Azotemia | 1 | 2023 | 6 | 0.220 |
Why?
| Disease Progression | 7 | 2019 | 2364 | 0.220 |
Why?
| Phosphorylation | 6 | 2019 | 1537 | 0.210 |
Why?
| Proprotein Convertase 9 | 1 | 2023 | 61 | 0.210 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2004 | 143 | 0.210 |
Why?
| Phenotype | 9 | 2021 | 2754 | 0.210 |
Why?
| Lipoxygenase Inhibitors | 2 | 2021 | 36 | 0.210 |
Why?
| Extracellular Matrix | 4 | 2021 | 433 | 0.200 |
Why?
| Rejuvenation | 1 | 2022 | 14 | 0.200 |
Why?
| Cell Line, Tumor | 9 | 2019 | 2690 | 0.200 |
Why?
| Cytokines | 4 | 2021 | 1795 | 0.200 |
Why?
| Zebrafish | 1 | 2006 | 407 | 0.200 |
Why?
| Programmed Cell Death 1 Receptor | 3 | 2020 | 193 | 0.200 |
Why?
| Polycystic Kidney Diseases | 2 | 2019 | 55 | 0.200 |
Why?
| DNA Helicases | 1 | 2023 | 133 | 0.190 |
Why?
| Arachidonate 12-Lipoxygenase | 1 | 2021 | 13 | 0.190 |
Why?
| Arachidonate 15-Lipoxygenase | 1 | 2021 | 16 | 0.190 |
Why?
| Aortic Valve Insufficiency | 1 | 2022 | 45 | 0.190 |
Why?
| Transcription Factors | 4 | 2023 | 1497 | 0.190 |
Why?
| Nephritis | 1 | 2021 | 20 | 0.190 |
Why?
| Cholesterol | 1 | 2023 | 365 | 0.190 |
Why?
| Metformin | 2 | 2023 | 273 | 0.190 |
Why?
| Female | 16 | 2023 | 59115 | 0.190 |
Why?
| Assisted Circulation | 1 | 2021 | 25 | 0.190 |
Why?
| Protein Kinase Inhibitors | 3 | 2023 | 779 | 0.190 |
Why?
| Adaptive Immunity | 2 | 2023 | 153 | 0.190 |
Why?
| Dual-Specificity Phosphatases | 1 | 2021 | 10 | 0.190 |
Why?
| Promoter Regions, Genetic | 5 | 2020 | 1110 | 0.190 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 2017 | 960 | 0.180 |
Why?
| Hypertrophy, Right Ventricular | 1 | 2021 | 140 | 0.180 |
Why?
| Ventricular Dysfunction, Right | 1 | 2023 | 216 | 0.180 |
Why?
| Homeostasis | 2 | 2022 | 561 | 0.180 |
Why?
| Wound Healing | 1 | 2022 | 253 | 0.170 |
Why?
| Aortic Diseases | 1 | 2021 | 105 | 0.170 |
Why?
| Blotting, Western | 3 | 2019 | 1128 | 0.170 |
Why?
| Antineoplastic Agents, Immunological | 2 | 2019 | 152 | 0.170 |
Why?
| Myocytes, Cardiac | 2 | 2014 | 447 | 0.170 |
Why?
| Jugular Veins | 1 | 2020 | 38 | 0.170 |
Why?
| Intestines | 1 | 2023 | 324 | 0.170 |
Why?
| Crohn Disease | 1 | 2023 | 196 | 0.170 |
Why?
| Chromatin | 1 | 2023 | 418 | 0.170 |
Why?
| Arachidonate 5-Lipoxygenase | 2 | 2019 | 43 | 0.170 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 112 | 0.170 |
Why?
| GATA4 Transcription Factor | 1 | 2019 | 17 | 0.160 |
Why?
| Kidney Tubules | 2 | 2019 | 107 | 0.160 |
Why?
| Wnt Signaling Pathway | 1 | 2020 | 145 | 0.160 |
Why?
| Pulmonary Artery | 3 | 2021 | 1012 | 0.160 |
Why?
| Azacitidine | 1 | 2020 | 130 | 0.160 |
Why?
| Neovascularization, Physiologic | 1 | 2000 | 174 | 0.160 |
Why?
| Epigenesis, Genetic | 1 | 2023 | 515 | 0.160 |
Why?
| Metabolome | 1 | 2021 | 275 | 0.160 |
Why?
| Catheterization | 4 | 2004 | 159 | 0.160 |
Why?
| AMP-Activated Protein Kinases | 2 | 2023 | 170 | 0.160 |
Why?
| Flow Cytometry | 2 | 2019 | 1065 | 0.150 |
Why?
| Sirolimus | 2 | 2014 | 181 | 0.150 |
Why?
| Bone Marrow | 2 | 2017 | 242 | 0.150 |
Why?
| Histocompatibility Antigens Class II | 1 | 2020 | 349 | 0.150 |
Why?
| Mice, Knockout, ApoE | 1 | 2018 | 8 | 0.150 |
Why?
| Skin | 1 | 2022 | 650 | 0.150 |
Why?
| Heart Ventricles | 2 | 2021 | 710 | 0.150 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2019 | 166 | 0.140 |
Why?
| Epithelial Cells | 3 | 2019 | 939 | 0.140 |
Why?
| Trans-Activators | 1 | 2020 | 356 | 0.140 |
Why?
| Interleukin-33 | 1 | 2017 | 38 | 0.140 |
Why?
| CD8-Positive T-Lymphocytes | 2 | 2021 | 686 | 0.140 |
Why?
| Receptors, Complement | 1 | 2017 | 111 | 0.140 |
Why?
| Immunotherapy | 2 | 2018 | 472 | 0.140 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 367 | 0.140 |
Why?
| Energy Metabolism | 1 | 2021 | 717 | 0.140 |
Why?
| Ventricular Remodeling | 2 | 2023 | 221 | 0.130 |
Why?
| Cell Cycle Proteins | 1 | 2019 | 543 | 0.130 |
Why?
| Gene Deletion | 2 | 2014 | 351 | 0.130 |
Why?
| B7-H1 Antigen | 1 | 2017 | 137 | 0.130 |
Why?
| Interferon-gamma | 1 | 2019 | 710 | 0.130 |
Why?
| Dinoprostone | 3 | 2016 | 178 | 0.120 |
Why?
| Autophagy | 2 | 2014 | 235 | 0.120 |
Why?
| Intracellular Signaling Peptides and Proteins | 3 | 2019 | 382 | 0.120 |
Why?
| Focal Adhesion Kinase 1 | 3 | 2003 | 27 | 0.120 |
Why?
| NF-kappa B | 2 | 2010 | 615 | 0.120 |
Why?
| Interleukin-6 | 3 | 2023 | 661 | 0.120 |
Why?
| Complement Activation | 1 | 2017 | 332 | 0.120 |
Why?
| Aorta | 3 | 2004 | 377 | 0.120 |
Why?
| Retinoid X Receptors | 1 | 2014 | 39 | 0.120 |
Why?
| Pleural Neoplasms | 1 | 2014 | 18 | 0.110 |
Why?
| Kidney Diseases | 1 | 2017 | 348 | 0.110 |
Why?
| Culture Media, Serum-Free | 2 | 2004 | 42 | 0.110 |
Why?
| Mesothelioma | 1 | 2014 | 31 | 0.110 |
Why?
| Gene Amplification | 1 | 2014 | 94 | 0.110 |
Why?
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 48 | 0.110 |
Why?
| RNA | 1 | 2019 | 801 | 0.110 |
Why?
| Leukotrienes | 1 | 2013 | 33 | 0.110 |
Why?
| Paracrine Communication | 1 | 2014 | 55 | 0.110 |
Why?
| Renal Insufficiency, Chronic | 1 | 2019 | 486 | 0.110 |
Why?
| Oligonucleotides, Antisense | 2 | 2004 | 95 | 0.110 |
Why?
| Eicosanoids | 1 | 2013 | 52 | 0.110 |
Why?
| Monocytes | 1 | 2016 | 499 | 0.100 |
Why?
| MAP Kinase Signaling System | 3 | 2021 | 267 | 0.100 |
Why?
| Myocardial Contraction | 1 | 2014 | 314 | 0.100 |
Why?
| Macrophage Activation | 1 | 2014 | 162 | 0.100 |
Why?
| Tumor Burden | 3 | 2020 | 257 | 0.100 |
Why?
| Macrophages, Alveolar | 1 | 2016 | 341 | 0.100 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2014 | 121 | 0.100 |
Why?
| Iloprost | 2 | 2010 | 46 | 0.100 |
Why?
| Up-Regulation | 2 | 2008 | 794 | 0.100 |
Why?
| Immunohistochemistry | 4 | 2021 | 1604 | 0.100 |
Why?
| Lipocalin-2 | 2 | 2023 | 62 | 0.100 |
Why?
| T-Lymphocytes | 2 | 2017 | 1725 | 0.100 |
Why?
| Endothelium, Vascular | 1 | 2018 | 829 | 0.100 |
Why?
| Heparitin Sulfate | 2 | 2003 | 39 | 0.090 |
Why?
| Protein Processing, Post-Translational | 2 | 2004 | 394 | 0.090 |
Why?
| Transforming Growth Factor beta | 1 | 2014 | 435 | 0.090 |
Why?
| Splenectomy | 1 | 2011 | 51 | 0.090 |
Why?
| Cyclooxygenase 2 | 2 | 2010 | 161 | 0.090 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2012 | 197 | 0.090 |
Why?
| Histone Deacetylases | 1 | 2012 | 194 | 0.090 |
Why?
| Green Fluorescent Proteins | 1 | 2011 | 365 | 0.090 |
Why?
| Frizzled Receptors | 1 | 2010 | 21 | 0.090 |
Why?
| p38 Mitogen-Activated Protein Kinases | 3 | 2015 | 244 | 0.080 |
Why?
| RNA, Small Interfering | 2 | 2010 | 528 | 0.080 |
Why?
| TRPP Cation Channels | 2 | 2019 | 63 | 0.080 |
Why?
| Reperfusion Injury | 1 | 2011 | 251 | 0.080 |
Why?
| Lung Injury | 1 | 2011 | 192 | 0.080 |
Why?
| Receptors, Epoprostenol | 1 | 2008 | 6 | 0.080 |
Why?
| Antineoplastic Agents | 2 | 2017 | 1872 | 0.080 |
Why?
| Severity of Illness Index | 2 | 2013 | 2530 | 0.080 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2010 | 182 | 0.080 |
Why?
| Adenosine Triphosphate | 2 | 2014 | 426 | 0.080 |
Why?
| Glycoproteins | 1 | 2010 | 302 | 0.070 |
Why?
| Hematopoietic Stem Cells | 1 | 2011 | 337 | 0.070 |
Why?
| Biomarkers | 4 | 2023 | 3389 | 0.070 |
Why?
| Receptors, CXCR4 | 1 | 2008 | 78 | 0.070 |
Why?
| Epoprostenol | 1 | 2008 | 132 | 0.070 |
Why?
| Cell Transformation, Neoplastic | 1 | 2010 | 305 | 0.070 |
Why?
| Gene Silencing | 2 | 2019 | 169 | 0.070 |
Why?
| Culture Media, Conditioned | 2 | 2014 | 103 | 0.070 |
Why?
| Neoplasm Metastasis | 1 | 2009 | 519 | 0.070 |
Why?
| Antihypertensive Agents | 1 | 2010 | 427 | 0.070 |
Why?
| RNA, Messenger | 5 | 2010 | 2507 | 0.070 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 248 | 0.070 |
Why?
| Pregnancy | 2 | 2016 | 5490 | 0.060 |
Why?
| Mutation | 3 | 2023 | 3313 | 0.060 |
Why?
| Apoptosis | 3 | 2020 | 2288 | 0.060 |
Why?
| Mitogens | 1 | 2005 | 56 | 0.060 |
Why?
| Neoplasm Transplantation | 2 | 2016 | 227 | 0.060 |
Why?
| Acetylation | 1 | 2006 | 208 | 0.060 |
Why?
| Animals, Genetically Modified | 1 | 2006 | 213 | 0.060 |
Why?
| Protein Subunits | 1 | 2006 | 200 | 0.060 |
Why?
| Gene Knockout Techniques | 2 | 2015 | 98 | 0.060 |
Why?
| Enzyme Inhibitors | 2 | 2007 | 737 | 0.060 |
Why?
| Middle Aged | 3 | 2021 | 26552 | 0.060 |
Why?
| Gene Expression Profiling | 3 | 2016 | 1510 | 0.060 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 155 | 0.060 |
Why?
| Cell Size | 2 | 2005 | 79 | 0.060 |
Why?
| Chromones | 1 | 2004 | 35 | 0.060 |
Why?
| Basement Membrane | 1 | 2003 | 29 | 0.060 |
Why?
| Androstadienes | 1 | 2004 | 97 | 0.050 |
Why?
| Embryo, Mammalian | 2 | 2003 | 211 | 0.050 |
Why?
| Acute-Phase Reaction | 1 | 2023 | 39 | 0.050 |
Why?
| Furosemide | 1 | 2023 | 32 | 0.050 |
Why?
| Tenascin | 1 | 2003 | 12 | 0.050 |
Why?
| Glycosaminoglycans | 1 | 2003 | 79 | 0.050 |
Why?
| Peroxidase | 2 | 2015 | 160 | 0.050 |
Why?
| Peroxidases | 1 | 2003 | 25 | 0.050 |
Why?
| Morpholines | 1 | 2004 | 102 | 0.050 |
Why?
| Aged | 2 | 2018 | 18944 | 0.050 |
Why?
| Fibronectins | 1 | 2003 | 104 | 0.050 |
Why?
| Transfection | 3 | 2014 | 842 | 0.050 |
Why?
| Murinae | 1 | 2022 | 2 | 0.050 |
Why?
| Ileum | 1 | 2023 | 92 | 0.050 |
Why?
| Aniline Compounds | 1 | 2023 | 70 | 0.050 |
Why?
| Case-Control Studies | 2 | 2021 | 2993 | 0.050 |
Why?
| Coculture Techniques | 2 | 2014 | 198 | 0.050 |
Why?
| Cadherins | 2 | 2016 | 170 | 0.050 |
Why?
| DNA Replication | 1 | 2003 | 200 | 0.050 |
Why?
| Metalloproteases | 1 | 2022 | 36 | 0.050 |
Why?
| Neoplasms | 1 | 2015 | 2082 | 0.050 |
Why?
| Cell Line | 2 | 2018 | 2581 | 0.050 |
Why?
| Matrix Metalloproteinases, Secreted | 1 | 2021 | 10 | 0.050 |
Why?
| Long Term Adverse Effects | 1 | 2021 | 10 | 0.050 |
Why?
| ADAMTS4 Protein | 1 | 2021 | 15 | 0.050 |
Why?
| Aorta, Thoracic | 1 | 2003 | 248 | 0.050 |
Why?
| Ventricular Function, Right | 1 | 2023 | 251 | 0.050 |
Why?
| Cellular Microenvironment | 1 | 2021 | 75 | 0.050 |
Why?
| Recombinant Fusion Proteins | 1 | 2003 | 599 | 0.050 |
Why?
| Liver | 2 | 2023 | 1630 | 0.040 |
Why?
| Vasoconstrictor Agents | 1 | 2021 | 113 | 0.040 |
Why?
| Leukocytes | 1 | 2021 | 268 | 0.040 |
Why?
| Major Histocompatibility Complex | 1 | 2021 | 217 | 0.040 |
Why?
| Blood Urea Nitrogen | 1 | 2020 | 51 | 0.040 |
Why?
| Butadienes | 1 | 2020 | 30 | 0.040 |
Why?
| Glomerular Filtration Rate | 1 | 2023 | 605 | 0.040 |
Why?
| Contractile Proteins | 1 | 2000 | 15 | 0.040 |
Why?
| Adult | 2 | 2018 | 30245 | 0.040 |
Why?
| Cell Fusion | 1 | 2000 | 50 | 0.040 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 331 | 0.040 |
Why?
| Proliferating Cell Nuclear Antigen | 1 | 2000 | 48 | 0.040 |
Why?
| Thiazolidinediones | 2 | 2011 | 134 | 0.040 |
Why?
| NADH, NADPH Oxidoreductases | 1 | 2019 | 14 | 0.040 |
Why?
| Growth Substances | 1 | 2000 | 136 | 0.040 |
Why?
| Enzyme Activation | 2 | 2014 | 752 | 0.040 |
Why?
| Genes, Tumor Suppressor | 1 | 2000 | 78 | 0.040 |
Why?
| ErbB Receptors | 1 | 2023 | 553 | 0.040 |
Why?
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2019 | 11 | 0.040 |
Why?
| Pyrimidinones | 1 | 2020 | 88 | 0.040 |
Why?
| Cloning, Molecular | 1 | 2000 | 514 | 0.040 |
Why?
| Mesoderm | 1 | 2020 | 130 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 387 | 0.040 |
Why?
| Nitriles | 1 | 2020 | 149 | 0.040 |
Why?
| Chemokine CXCL9 | 1 | 2019 | 20 | 0.040 |
Why?
| Tropoelastin | 1 | 1999 | 11 | 0.040 |
Why?
| Receptors, Leukotriene | 1 | 2019 | 13 | 0.040 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2019 | 51 | 0.040 |
Why?
| Pyridones | 1 | 2020 | 122 | 0.040 |
Why?
| Luciferases | 2 | 2010 | 139 | 0.040 |
Why?
| Drug Resistance, Neoplasm | 1 | 2023 | 636 | 0.040 |
Why?
| Fibroblasts | 1 | 2003 | 827 | 0.040 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2003 | 777 | 0.040 |
Why?
| Proteoglycans | 1 | 1999 | 107 | 0.040 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 227 | 0.040 |
Why?
| Aortic Valve | 1 | 2022 | 391 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 914 | 0.040 |
Why?
| Antibodies, Blocking | 1 | 2017 | 32 | 0.040 |
Why?
| Tumor Cells, Cultured | 2 | 2010 | 834 | 0.040 |
Why?
| Complement C3d | 1 | 2017 | 60 | 0.040 |
Why?
| Neoplasm Proteins | 1 | 2020 | 381 | 0.030 |
Why?
| Complement C3 | 1 | 2017 | 182 | 0.030 |
Why?
| Myocardial Ischemia | 1 | 2018 | 237 | 0.030 |
Why?
| Molecular Targeted Therapy | 1 | 2019 | 345 | 0.030 |
Why?
| Immunoglobulin M | 1 | 2017 | 244 | 0.030 |
Why?
| Arachidonic Acid | 1 | 2016 | 110 | 0.030 |
Why?
| Immunocompetence | 1 | 2016 | 40 | 0.030 |
Why?
| Oncogene Proteins, Fusion | 1 | 2017 | 178 | 0.030 |
Why?
| Time Factors | 2 | 2017 | 6032 | 0.030 |
Why?
| Lymphocyte Depletion | 1 | 2015 | 115 | 0.030 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 139 | 0.030 |
Why?
| Organ Culture Techniques | 2 | 2007 | 140 | 0.030 |
Why?
| Kidney Function Tests | 1 | 2015 | 139 | 0.030 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2017 | 693 | 0.030 |
Why?
| Homozygote | 1 | 2015 | 186 | 0.030 |
Why?
| Ventricular Function, Left | 1 | 2018 | 469 | 0.030 |
Why?
| Chemokines | 1 | 2016 | 214 | 0.030 |
Why?
| Caspase 3 | 1 | 2015 | 227 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 310 | 0.030 |
Why?
| Carcinogenesis | 1 | 2016 | 172 | 0.030 |
Why?
| Proto-Oncogene Proteins c-sis | 2 | 2005 | 33 | 0.030 |
Why?
| Tetrahydronaphthalenes | 1 | 2014 | 29 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 435 | 0.030 |
Why?
| Heart | 1 | 2018 | 609 | 0.030 |
Why?
| Intracellular Space | 1 | 2014 | 67 | 0.030 |
Why?
| Chemokine CCL2 | 1 | 2014 | 103 | 0.030 |
Why?
| Macrophage Colony-Stimulating Factor | 1 | 2014 | 17 | 0.030 |
Why?
| Pyridazines | 1 | 2014 | 46 | 0.030 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2014 | 81 | 0.030 |
Why?
| Ventricular Myosins | 1 | 2014 | 33 | 0.030 |
Why?
| Clone Cells | 1 | 2014 | 245 | 0.030 |
Why?
| Superoxides | 1 | 2014 | 186 | 0.030 |
Why?
| Microfilament Proteins | 1 | 2014 | 125 | 0.030 |
Why?
| Muscle, Skeletal | 1 | 2022 | 1417 | 0.030 |
Why?
| Cardiomegaly | 1 | 2014 | 158 | 0.030 |
Why?
| Hypoglycemic Agents | 2 | 2011 | 1006 | 0.030 |
Why?
| Imidazoles | 1 | 2014 | 203 | 0.030 |
Why?
| Cardiac Surgical Procedures | 1 | 2017 | 408 | 0.030 |
Why?
| Calcium-Binding Proteins | 1 | 2014 | 201 | 0.030 |
Why?
| Biomarkers, Tumor | 1 | 2019 | 1029 | 0.030 |
Why?
| Integrases | 1 | 2014 | 116 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2016 | 438 | 0.030 |
Why?
| Mice, Nude | 1 | 2014 | 625 | 0.030 |
Why?
| Metabolic Networks and Pathways | 1 | 2013 | 167 | 0.030 |
Why?
| Femoral Artery | 1 | 2014 | 165 | 0.030 |
Why?
| Capillary Leak Syndrome | 1 | 2011 | 12 | 0.020 |
Why?
| Vasoconstriction | 1 | 2012 | 174 | 0.020 |
Why?
| Chemokine CXCL1 | 1 | 2011 | 67 | 0.020 |
Why?
| Benzamides | 1 | 2012 | 168 | 0.020 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 1236 | 0.020 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 162 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2011 | 383 | 0.020 |
Why?
| Cell Lineage | 1 | 2012 | 305 | 0.020 |
Why?
| Snail Family Transcription Factors | 1 | 2010 | 16 | 0.020 |
Why?
| Regional Blood Flow | 1 | 2012 | 407 | 0.020 |
Why?
| Models, Animal | 1 | 2011 | 337 | 0.020 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2010 | 76 | 0.020 |
Why?
| Spleen | 1 | 2011 | 480 | 0.020 |
Why?
| Interleukin-10 | 1 | 2011 | 288 | 0.020 |
Why?
| Matrix Metalloproteinases | 1 | 2010 | 88 | 0.020 |
Why?
| Interleukin-1beta | 1 | 2011 | 364 | 0.020 |
Why?
| Metabolomics | 1 | 2013 | 508 | 0.020 |
Why?
| Pyrimidines | 1 | 2012 | 372 | 0.020 |
Why?
| Myocardium | 1 | 2014 | 906 | 0.020 |
Why?
| Intramolecular Oxidoreductases | 1 | 2008 | 56 | 0.020 |
Why?
| Cell Adhesion | 1 | 2010 | 423 | 0.020 |
Why?
| Pyridines | 1 | 2012 | 417 | 0.020 |
Why?
| Prognosis | 1 | 2016 | 3318 | 0.020 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2008 | 108 | 0.020 |
Why?
| Drug Evaluation, Preclinical | 1 | 2008 | 158 | 0.020 |
Why?
| Sulindac | 1 | 2007 | 17 | 0.020 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 48 | 0.020 |
Why?
| Culture Media | 1 | 2007 | 151 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2007 | 271 | 0.020 |
Why?
| Transgenes | 1 | 2007 | 169 | 0.020 |
Why?
| Neoplasms, Experimental | 1 | 2007 | 149 | 0.020 |
Why?
| Respiratory Mucosa | 1 | 2008 | 251 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2011 | 1106 | 0.020 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2005 | 3 | 0.020 |
Why?
| Genes, jun | 1 | 2005 | 9 | 0.020 |
Why?
| Blood Pressure | 1 | 2012 | 1521 | 0.020 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 34 | 0.020 |
Why?
| Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 14 | 0.020 |
Why?
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2005 | 14 | 0.020 |
Why?
| Genetic Markers | 1 | 2005 | 318 | 0.010 |
Why?
| Genotype | 1 | 2008 | 1733 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2007 | 1822 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2005 | 331 | 0.010 |
Why?
| Heparin Lyase | 1 | 2003 | 4 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 739 | 0.010 |
Why?
| Cattle | 1 | 2004 | 913 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 2003 | 786 | 0.010 |
Why?
| Binding Sites | 1 | 2003 | 1153 | 0.010 |
Why?
| Homeodomain Proteins | 1 | 2003 | 460 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 1999 | 71 | 0.010 |
Why?
| In Situ Hybridization | 1 | 1999 | 285 | 0.010 |
Why?
| Tissue Distribution | 1 | 1999 | 280 | 0.010 |
Why?
| Muscle Development | 1 | 1999 | 93 | 0.010 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 1286 | 0.010 |
Why?
| Models, Biological | 1 | 2003 | 1589 | 0.010 |
Why?
| Gestational Age | 1 | 1999 | 762 | 0.010 |
Why?
| DNA | 1 | 1999 | 1331 | 0.010 |
Why?
|
|
Weiser-Evans's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|